A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the delivery of first shipments of lenacapavir – Gilead’s twice-yearly ...
Lenacapavir is an injectable medicine that only needs to be taken twice a year, making it easier to use than daily HIV pills.
B.C. medical breakthrough led to a global decline in HIV cases. Now a patient and the doctor who pioneered the treatment are both raising concerns that recent international funding cuts may threaten ...
10d
Injectable PrEP approved in Northern Ireland following NHS milestone in monumental HIV breakthrough
"Eligible patients in Northern Ireland may receive this treatment," says the Department of Health The post Injectable PrEP ...
The Department of Health said the decision reflects its mandate to ensure that all citizens have access to safe, effective, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent." In this state, they are largely invisible and unassailable. As long as ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Hosted on MSN
HIV knows no borders, and the Trump administration's new strategy leaves Americans vulnerable, expert explains
Protecting public health abroad benefits Americans. In a globalized world, diseases and their social and economic impacts do not stay within national boundaries. Increased rates of untreated HIV in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback